Status:
RECRUITING
Prospective Cohort Study on the Determinants of Venous THromboembolic Recurrence
Lead Sponsor:
University Hospital, Brest
Conditions:
Thromboembolic Venous Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
The main objective of the BREIZH-Cohorte study is to determine the incidence of recurrent short, medium and long-term thromboembolic venous disease as well as risk factors for recurrence in two specif...
Detailed Description
Deep vein thrombosis (DVT) and pulmonary embolism (PE) are two clinical manifestations of the same entity, thromboembolic venous disease. This disease is frequent: the annual incidence of thromboembol...
Eligibility Criteria
Inclusion
- Subject aged 18 or over, or a minor with the consent of the parents and the minor, presenting with a thromboembolic venous disease
- 50 and under or any age if active cancer
- Affiliated to social security
- Accepting to participate in the study.
Exclusion
- Inability to communicate (comprehension disorder).
- Refusal to participate.
Key Trial Info
Start Date :
May 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2050
Estimated Enrollment :
3400 Patients enrolled
Trial Details
Trial ID
NCT04297085
Start Date
May 28 2020
End Date
April 1 2050
Last Update
September 12 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Brest
Brest, France, 29200
2
HIA Clermont Tonnerre Brest
Brest, France, 29200
3
CH Morlaix
Morlaix, France, 29672
4
CH de Cornouaille
Quimper, France, 29107